Require strict medical testing, regulation, and FDA approval
Both drugs : Share GLP-1 and glucagon receptor agonism, once-weekly subcutaneous dosing, similar GI side effect profiles, and investigational status
Sleep is a multifaceted process, and the best outcomes come from strategically combining peptides that target different aspects of the sleep-recovery cycle
18 March 2025 Last September, the World Anti-Doping Agency (WADA) published the 2025 List of Prohibited Substances and Methods , the international standard for banned substances and their related compounds in sports
Possible Side Effects Observed in Research Settings Because Retatrutide interacts with GLP-1, GIP, and glucagon receptor pathways, observed responses in research settings are commonly gastrointestinal and metabolic in nature
Cons They dont offer lifestyle coaching